Search

everythinglearnresearchcommunity

for

Search:↓

Laser therapy on human skin affects the HERC6 gene and related genes, influencing many cell processes and requiring careful safety measures.

EGFR helps hair follicles transition properly by controlling Stathmin levels.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

CRABP2 helps increase the growth of cells important for hair growth by activating a specific growth pathway.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Finasteride may help treat childhood brain tumors by activating certain genes.

Blocking a specific receptor slows down hair loss in mice.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

Bcl-2 helps hair regeneration but can also increase cancer risk.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

RCS-01 is safe and may help rejuvenate aging skin.

NEDD4 and NEDD4L help control intestinal stem cells and prevent tumors by breaking down the LGR5 receptor.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Wnt signaling is crucial for Hedgehog-driven skin tumor growth.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

RNase L hinders hair follicle regeneration by altering immune signals.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Some blood pressure medications are linked to a higher risk of skin cancer.